疫苗廠商或發"安全宣言"
Vaccine makers plan public stance
疫苗廠商或發“安全宣言”
Drugmakers are planning a public pledge to not send any COVID-19 vaccine to the US Food and Drug Administration for review without extensive safety and efficacy data, according to people familiar with the effort. The joint stance is seen as a bulwark against political pressure being applied on the FDA to get a vaccine out as soon as possible.
知情人士稱，多家制藥公司正計劃發表公開聯合承諾，如果沒有得到廣泛的安全性和有效性測試數據，不會將任何新冠疫苗送交美國食品和藥品管理局（FDA）審批。
The companies involved in the discussions include Pfizer Inc, Moderna Inc, Johnson and Johnson, GlaxoSmithKline Plc, Sanofi, and possibly others. All are developing vaccines for COVID-19.
FDA正面臨儘快批准疫苗的政治壓力，這些製藥公司的聯合立場是對這種情況的防備。參與討論的公司包括輝瑞、莫德納、強生，葛蘭素史克、賽諾菲等，這些藥企都在研發新冠疫苗。
The drug industry has long relied on the FDA as a gold-standard approver for its drugs. But in the middle of the pandemic, the agency has made several controversial decisions to allow emergency use of therapies without rock-solid evidence they work.
製藥業向來以FDA的審批作爲藥品的黃金標準，但在此次疫情期間，FDA做出了幾次有爭議的決定，在沒有確定療效前就允許緊急使用一些新冠療法。
One recent poll found a majority of the US public thought a vaccine approval would be driven by politics.
最近一項民調顯示，多數受訪美國民衆認爲，新冠疫苗的審批將會被政治化。
US President Donald Trump has accused the FDA of slowing work to hurt him politically, and said he believes a vaccine will be ready before Election Day on Nov 3.
美國總統特朗普指責FDA故意拖延疫苗工作，目的是在政治上給他造成傷害，他還表示，新冠疫苗能夠在11月3日大選前準備好。
